drugset / Trial / NCT01210183
Biological Response of Stage IV Knee Osteoarthritis to Serial 12.5% Dextrose
NaSingle-groupSingle-blindTreatment
Summary
Dextrose injection in end-stage knee arthritis will cause growth of cartilage cells in a particular area of complete cartilage loss. Dextrose concentration will be 12.5%. Cartilage status will be monitored by pre and post treatment arthroscopy views with specialized (methylene blue) staining for cartilage.
Timeline
- Start
- 2010-07
- Primary completion
- 2013-12
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dextrose | Unknown | 9 ml | Other |
| Subject | Dextrose | Unknown | 12.5 % | Other |